- Home
- HCTI vs ALLR Comparison
HCTI vs ALLR Comparison
Compare HCTI & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- ALLR
- Stock Information
- Founded
- HCTI 2020
- ALLR 2004
- Country
- HCTI United States
- ALLR United States
- Employees
- HCTI N/A
- ALLR N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- ALLR Health Care
- Exchange
- HCTI Nasdaq
- ALLR Nasdaq
- Market Cap
- HCTI 13.5M
- ALLR 15.8M
- IPO Year
- HCTI 2021
- ALLR N/A
- Fundamental
- Price
- HCTI $0.03
- ALLR $1.01
- Analyst Decision
- HCTI
- ALLR
- Analyst Count
- HCTI 0
- ALLR 0
- Target Price
- HCTI N/A
- ALLR N/A
- AVG Volume (30 Days)
- HCTI 709.7M
- ALLR 431.7K
- Earning Date
- HCTI 08-18-2025
- ALLR 08-04-2025
- Dividend Yield
- HCTI N/A
- ALLR N/A
- EPS Growth
- HCTI N/A
- ALLR N/A
- EPS
- HCTI N/A
- ALLR N/A
- Revenue
- HCTI $11,291,000.00
- ALLR N/A
- Revenue This Year
- HCTI N/A
- ALLR N/A
- Revenue Next Year
- HCTI N/A
- ALLR N/A
- P/E Ratio
- HCTI N/A
- ALLR N/A
- Revenue Growth
- HCTI N/A
- ALLR N/A
- 52 Week Low
- HCTI $0.01
- ALLR $0.61
- 52 Week High
- HCTI $1.90
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- HCTI 41.79
- ALLR 55.83
- Support Level
- HCTI $0.02
- ALLR $0.96
- Resistance Level
- HCTI $0.03
- ALLR $1.09
- Average True Range (ATR)
- HCTI 0.01
- ALLR 0.07
- MACD
- HCTI 0.01
- ALLR 0.02
- Stochastic Oscillator
- HCTI 38.89
- ALLR 73.33
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.